NM_000507.4:c.426+7C>T

Variant summary

Our verdict is Benign. The variant received -20 ACMG points: 0P and 20B. BP4_StrongBP6_Very_StrongBA1

The NM_000507.4(FBP1):​c.426+7C>T variant causes a splice region, intron change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.34 in 1,590,510 control chromosomes in the GnomAD database, including 95,582 homozygotes. In-silico tool predicts a benign outcome for this variant. 3/3 splice prediction tools predict no significant impact on normal splicing. Variant has been reported in ClinVar as Benign (★★).

Frequency

Genomes: 𝑓 0.32 ( 7989 hom., cov: 32)
Exomes 𝑓: 0.34 ( 87593 hom. )

Consequence

FBP1
NM_000507.4 splice_region, intron

Scores

2
Splicing: ADA: 0.0003523
2

Clinical Significance

Benign criteria provided, multiple submitters, no conflicts B:8

Conservation

PhyloP100: 0.387
Variant links:
Genes affected
FBP1 (HGNC:3606): (fructose-bisphosphatase 1) Fructose-1,6-bisphosphatase 1, a gluconeogenesis regulatory enzyme, catalyzes the hydrolysis of fructose 1,6-bisphosphate to fructose 6-phosphate and inorganic phosphate. Fructose-1,6-diphosphatase deficiency is associated with hypoglycemia and metabolic acidosis. [provided by RefSeq, Jul 2008]

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -20 ACMG points.

BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.79).
BP6
Variant 9-94617761-G-A is Benign according to our data. Variant chr9-94617761-G-A is described in ClinVar as [Benign]. Clinvar id is 256320.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr9-94617761-G-A is described in Lovd as [Benign].
BA1
GnomAd4 highest subpopulation (EAS) allele frequency at 95% confidence interval = 0.537 is higher than 0.05.

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
FBP1NM_000507.4 linkc.426+7C>T splice_region_variant, intron_variant Intron 3 of 6 ENST00000375326.9 NP_000498.2 P09467
FBP1NM_001127628.2 linkc.426+7C>T splice_region_variant, intron_variant Intron 4 of 7 NP_001121100.1 P09467Q2TU34
FBP1XM_006717005.5 linkc.180+7C>T splice_region_variant, intron_variant Intron 3 of 6 XP_006717068.1

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
FBP1ENST00000375326.9 linkc.426+7C>T splice_region_variant, intron_variant Intron 3 of 6 1 NM_000507.4 ENSP00000364475.5 P09467

Frequencies

GnomAD3 genomes
AF:
0.321
AC:
48755
AN:
151770
Hom.:
7978
Cov.:
32
show subpopulations
Gnomad AFR
AF:
0.284
Gnomad AMI
AF:
0.242
Gnomad AMR
AF:
0.234
Gnomad ASJ
AF:
0.232
Gnomad EAS
AF:
0.555
Gnomad SAS
AF:
0.393
Gnomad FIN
AF:
0.389
Gnomad MID
AF:
0.275
Gnomad NFE
AF:
0.336
Gnomad OTH
AF:
0.302
GnomAD2 exomes
AF:
0.336
AC:
84275
AN:
250660
AF XY:
0.341
show subpopulations
Gnomad AFR exome
AF:
0.280
Gnomad AMR exome
AF:
0.192
Gnomad ASJ exome
AF:
0.239
Gnomad EAS exome
AF:
0.551
Gnomad FIN exome
AF:
0.386
Gnomad NFE exome
AF:
0.338
Gnomad OTH exome
AF:
0.324
GnomAD4 exome
AF:
0.343
AC:
492730
AN:
1438622
Hom.:
87593
Cov.:
29
AF XY:
0.344
AC XY:
246727
AN XY:
717162
show subpopulations
African (AFR)
AF:
0.272
AC:
8981
AN:
33062
American (AMR)
AF:
0.195
AC:
8697
AN:
44666
Ashkenazi Jewish (ASJ)
AF:
0.240
AC:
6257
AN:
26032
East Asian (EAS)
AF:
0.585
AC:
23140
AN:
39536
South Asian (SAS)
AF:
0.383
AC:
32886
AN:
85754
European-Finnish (FIN)
AF:
0.399
AC:
21231
AN:
53236
Middle Eastern (MID)
AF:
0.241
AC:
1380
AN:
5724
European-Non Finnish (NFE)
AF:
0.340
AC:
370543
AN:
1090986
Other (OTH)
AF:
0.329
AC:
19615
AN:
59626
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.466
Heterozygous variant carriers
0
14151
28303
42454
56606
70757
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Exome Hom
Variant carriers
0
11912
23824
35736
47648
59560
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.321
AC:
48804
AN:
151888
Hom.:
7989
Cov.:
32
AF XY:
0.322
AC XY:
23877
AN XY:
74226
show subpopulations
African (AFR)
AF:
0.285
AC:
11787
AN:
41404
American (AMR)
AF:
0.234
AC:
3565
AN:
15252
Ashkenazi Jewish (ASJ)
AF:
0.232
AC:
805
AN:
3470
East Asian (EAS)
AF:
0.554
AC:
2858
AN:
5158
South Asian (SAS)
AF:
0.392
AC:
1880
AN:
4800
European-Finnish (FIN)
AF:
0.389
AC:
4096
AN:
10526
Middle Eastern (MID)
AF:
0.276
AC:
81
AN:
294
European-Non Finnish (NFE)
AF:
0.336
AC:
22867
AN:
67968
Other (OTH)
AF:
0.306
AC:
644
AN:
2104
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.503
Heterozygous variant carriers
0
1689
3377
5066
6754
8443
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
506
1012
1518
2024
2530
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.317
Hom.:
12526
Bravo
AF:
0.306
Asia WGS
AF:
0.422
AC:
1465
AN:
3478
EpiCase
AF:
0.329
EpiControl
AF:
0.328

ClinVar

Significance: Benign
Submissions summary: Benign:8
Revision: criteria provided, multiple submitters, no conflicts
LINK: link

Submissions by phenotype

not specified Benign:3
Aug 30, 2012
PreventionGenetics, part of Exact Sciences
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

-
Joint Genome Diagnostic Labs from Nijmegen and Maastricht, Radboudumc and MUMC+
Significance:Benign
Review Status:no assertion criteria provided
Collection Method:clinical testing

- -

-
Diagnostic Laboratory, Department of Genetics, University Medical Center Groningen
Significance:Benign
Review Status:no assertion criteria provided
Collection Method:clinical testing

- -

Fructose-biphosphatase deficiency Benign:3
Aug 10, 2021
Genome-Nilou Lab
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Feb 03, 2025
Labcorp Genetics (formerly Invitae), Labcorp
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Jan 13, 2018
Illumina Laboratory Services, Illumina
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

This variant was observed in the ICSL laboratory as part of a predisposition screen in an ostensibly healthy population. It had not been previously curated by ICSL or reported in the Human Gene Mutation Database (HGMD: prior to June 1st, 2018), and was therefore a candidate for classification through an automated scoring system. Utilizing variant allele frequency, disease prevalence and penetrance estimates, and inheritance mode, an automated score was calculated to assess if this variant is too frequent to cause the disease. Based on the score and internal cut-off values, a variant classified as benign is not then subjected to further curation. The score for this variant resulted in a classification of benign for this disease. -

not provided Benign:2
Mar 03, 2015
GeneDx
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

-
Breakthrough Genomics, Breakthrough Genomics
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:not provided

- -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
-0.79
CADD
Benign
2.5
DANN
Benign
0.41
PhyloP100
0.39
Mutation Taster
=100/0
polymorphism (auto)

Splicing

Name
Calibrated prediction
Score
Prediction
dbscSNV1_ADA
Benign
0.00035
dbscSNV1_RF
Benign
0.028
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs8192689; hg19: chr9-97380043; COSMIC: COSV107478007; API